‘A constellation of symptoms’: Long COVID in focus The first public hearing into long COVID has taken place as clinicians attempt to work out the scale of the problem, and one GP reports a rising demand for treatment.
Doubts over impact of key antiviral treatment A large UK study suggests molnupiravir has no effect on hospitalisations and deaths but reduces the overall recovery time from COVID-19.
RACGP backs IMG red tape reduction Federal Government bureaucracy can be cut but the college makes no apology for ensuring standards are maintained, says RACGP Rural Chair.
Could ‘nurse navigators’ help the severely mentally ill? People with serious mental illness are dying much earlier than average from entirely preventable diseases, a situation a new policy aims to improve.
Massive shortage in projected care workforce flagged Workers required to care for Australia’s most vulnerable may fall short by more than 200,000 people by 2050, a new report has warned.
Army veteran GP reacts to suicide report recommendations The Government has apologised for the failures of ‘successive governments’ in response to an interim report from the Royal Commission into Defence and Veteran Suicide.
New RACGP Specific Interests Chairs welcomed The new Chairs of the college’s Specific Interests groups were recently voted in and are set to assume their roles from 12 October.
Joint appeal issued for delay of 30/20 telehealth rule The new compliance measure is being introduced today, despite the lingering threat posed by the COVID-19 pandemic.
TGA approves second COVID-19 vaccine for youngest children The Pfizer vaccine is now approved for use in children aged six months to five years, with Moderna already available to the age group.
Medicinal cannabis companies ‘undermined doctor–patient relationship’ Almost $1 million in fines have been issued to companies for unlawfully advertising prescription-only medicinal cannabis products.